Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.67 |
| ▸ | HPGD | P15428 | 4/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.67 |
| ▸ | TFEB | P19484 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 5/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.60 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | BCHE | P06276 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15188 | 1.00 | KDM4E (0.67) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL13957562 | 1.00 | KDM4E (0.67) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL31506312 | 1.00 | KDM4E (0.67) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL1205800 | 0.91 | MAPT (0.61) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL1205797 | 0.91 | MAPT (0.61) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL16852753 | 0.89 | KDM4E (0.55) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL2474892 | 0.88 | KDM4E (0.72) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL19244433 | 0.88 | KDM4E (0.72) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL3536947 | 0.88 | SMN1; SMN2 (0.60) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 | |
| SCHEMBL3536949 | 0.88 | SMN1; SMN2 (0.60) | KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119528981-A | Chiral phosphonate compound and derivative thereof, preparation method, pesticide bacteriostat and application | 贵州大学 | 2025-02-28 | — | — | CN | claimed |
| CN-119528981-A | Chiral phosphonate compound and derivative thereof, preparation method, pesticide bacteriostat and application | 贵州大学 | 2025-02-28 | — | — | CN | disclosed |
| CN-116023202-A | Synthetic method of alpha-chlorarone derivative | 西南大学 | 2023-04-28 | — | — | CN | disclosed |
| CN-112851624-A | Synthetic method of 2-benzoxazepine compound | 云南大学 | 2021-05-28 | — | — | CN | disclosed |
| EP-3208301-B1 | RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME | TOSOH CORP (JP) | 2019-04-03 | — | — | EP | disclosed |
| US-10126478-B2 | Resin composition and optical compensation film using same | TOSOH CORPORATION (JP) | 2018-11-13 | — | — | US | disclosed |
| US-20170242174-A1 | RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME | TOSOH CORPORATION (JP) | 2017-08-24 | — | — | US | disclosed |
| EP-3208301-A1 | RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME | Tosoh Corporation (JP) | 2017-08-23 | — | — | EP | disclosed |
| US-7462713-B2 | Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy | AGOURON PHARMACEUTICALS, INC. (US) | 2008-12-09 | — | — | US | disclosed |
| US-7462713-B2 | Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy | AGOURON PHARMACEUTICALS, INC. (US) | 2008-12-09 | — | — | US | disclosed |
| WO-2004063198-A1 | DIAZEPINOINDOLE DERIVATIVES AS KINASE INHIBITORS | PFIZER INC. (US) | 2004-07-29 | — | — | WO | disclosed |
| EP-0844000-A1 | Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis | SANKYO COMPANY LIMITED (JP) | 1998-05-27 | — | — | EP | disclosed |
| US-5556864-A | TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS | SANKYO COMPANY, LIMITED (JP) | 1996-09-17 | — | — | US | disclosed |
| EP-0600717-A1 | Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis | SANKYO COMPANY LIMITED (JP) | 1994-06-08 | — | — | EP | disclosed |
| EP-0190496-A2 | Piperidine derivatives having a gastro-intestinal activity | BEECHAM GROUP PLC (GB) | 1986-08-13 | — | — | EP | disclosed |
| US-3987176-A | COMPOSITION AND USE OF 3,4-DIHYDROPYRIDONES AS VASODILATORS AND ANTIHYPERTENSIVE AGENTS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-10-19 | — | — | US | disclosed |
| US-3981882-A | HYPOTENSIVE AGENTS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-09-21 | — | — | US | disclosed |
| US-3951990-A | CORONARY AGENTS, HYPOTENSIVE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-20 | — | — | US | disclosed |
| US-3951992-A | CORONARY, HYPOTENSIVE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-20 | — | — | US | disclosed |
| US-3951991-A | CORONARY AGENTS, HYPOTENSIVE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-20 | — | — | US | disclosed |